YU11301A - Novi oblik soli pantoprazola - Google Patents

Novi oblik soli pantoprazola

Info

Publication number
YU11301A
YU11301A YU11301A YUP11301A YU11301A YU 11301 A YU11301 A YU 11301A YU 11301 A YU11301 A YU 11301A YU P11301 A YUP11301 A YU P11301A YU 11301 A YU11301 A YU 11301A
Authority
YU
Yugoslavia
Prior art keywords
pantroprazole
salt form
novel salt
novel
pantoprazole
Prior art date
Application number
YU11301A
Other languages
English (en)
Inventor
Bernhard Kohl
Original Assignee
Altana Pharma Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU11301(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag. filed Critical Altana Pharma Ag.
Priority to MEP-2008-847A priority Critical patent/ME00562B/me
Publication of YU11301A publication Critical patent/YU11301A/sh
Publication of RS50071B publication Critical patent/RS50071B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)

Abstract

Pronalazak se odnosi na dihidrat magnezijumove soli pantoprazola.[The invention relates to the dihydrate of the magnesium salt of pantoprazole.
YUP-113/01A 1998-08-18 1999-08-12 Novi oblik soli pantoprazola RS50071B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-2008-847A ME00562B (me) 1998-08-18 1999-08-12 Novi oblik soli pantoprazola

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol

Publications (2)

Publication Number Publication Date
YU11301A true YU11301A (sh) 2003-12-31
RS50071B RS50071B (sr) 2009-01-22

Family

ID=7881823

Country Status (33)

Country Link
US (2) US6410569B1 (sh)
EP (1) EP1105386B1 (sh)
JP (1) JP2002523411A (sh)
KR (1) KR100657835B1 (sh)
CN (1) CN1146558C (sh)
AT (1) ATE219074T1 (sh)
AU (1) AU761715B2 (sh)
BG (1) BG65255B1 (sh)
BR (1) BR9914288A (sh)
CA (1) CA2341031C (sh)
CZ (1) CZ293734B6 (sh)
DE (3) DE19843413C1 (sh)
DK (1) DK1105386T3 (sh)
EA (1) EA004431B1 (sh)
EE (1) EE04278B1 (sh)
ES (1) ES2178896T3 (sh)
HK (1) HK1037616A1 (sh)
HR (1) HRP20010117B1 (sh)
HU (1) HU226618B1 (sh)
IL (3) IL141157A0 (sh)
ME (1) ME00562B (sh)
MX (1) MXPA01001758A (sh)
NO (1) NO319782B1 (sh)
NZ (1) NZ509761A (sh)
PL (1) PL198801B1 (sh)
PT (1) PT1105386E (sh)
RS (1) RS50071B (sh)
SI (1) SI1105386T1 (sh)
SK (1) SK285105B6 (sh)
TR (1) TR200100287T2 (sh)
UA (1) UA58605C2 (sh)
WO (1) WO2000010995A1 (sh)
ZA (1) ZA200100934B (sh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
CA2510849A1 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
MXPA05011699A (es) * 2003-05-06 2006-01-23 Altana Pharma Ag Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CN1791406A (zh) * 2003-05-19 2006-06-21 普利瓦研究与发展有限公司 5－(二氟甲氧基)－2－[[(3,4－二甲氧基－2－吡啶基)甲基]亚硫酰基]－1h－苯并咪唑(泮托拉唑)钠水络合物的固态形式
MXPA05013316A (es) * 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US20060189590A1 (en) * 2003-07-23 2006-08-24 Bernhard Kohl Alkaline salts of proton pump inhibitors
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
EP1711179A2 (en) * 2004-01-28 2006-10-18 Altana Pharma AG Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005077936A1 (en) * 2004-02-11 2005-08-25 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides with high purity
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
ATE531361T1 (de) * 2004-05-07 2011-11-15 Nycomed Gmbh Neue pharmazeutische dosierform und herstellungsverfahren
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
US20080177076A1 (en) * 2006-11-06 2008-07-24 Lilach Hedvanti Processes for preparing substantially pure pantoprazole magnesium
SI3397630T1 (sl) * 2015-12-30 2021-11-30 Krka, tovarna zdravil, d.d., Novo mesto, Postoek za pripravo natrijevega pantoprazolata seskvihidrata
EP3187494A1 (en) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of pantoprazole sodium sesquihydrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
KR20010072487A (ko) 2001-07-31
ME00562A (en) 2011-12-20
DE122005000049I1 (de) 2006-12-28
BR9914288A (pt) 2001-06-19
AU5515699A (en) 2000-03-14
ME00562B (me) 2011-12-20
HRP20010117B1 (en) 2010-07-31
HRP20010117A2 (en) 2002-02-28
EE200100054A (et) 2002-06-17
CA2341031C (en) 2006-04-04
UA58605C2 (uk) 2003-08-15
IL141157A0 (en) 2002-02-10
NZ509761A (en) 2003-08-29
EA200100208A1 (ru) 2001-08-27
ZA200100934B (en) 2002-03-04
US6686379B2 (en) 2004-02-03
US20020188008A1 (en) 2002-12-12
CN1318065A (zh) 2001-10-17
EA004431B1 (ru) 2004-04-29
HUP0103257A3 (en) 2003-01-28
PL198801B1 (pl) 2008-07-31
NO319782B1 (no) 2005-09-12
PT1105386E (pt) 2002-11-29
SK285105B6 (sk) 2006-06-01
KR100657835B1 (ko) 2006-12-15
EP1105386A1 (en) 2001-06-13
DE69901840D1 (de) 2002-07-18
ATE219074T1 (de) 2002-06-15
HU226618B1 (en) 2009-04-28
US6410569B1 (en) 2002-06-25
DK1105386T3 (da) 2002-09-30
SI1105386T1 (en) 2002-12-31
CZ2001621A3 (cs) 2001-08-15
NO20010718D0 (no) 2001-02-12
HUP0103257A2 (hu) 2002-02-28
CZ293734B6 (cs) 2004-07-14
EE04278B1 (et) 2004-04-15
SK2362001A3 (en) 2001-09-11
IL141157A (en) 2007-06-17
DE19843413C1 (de) 2000-03-30
ES2178896T3 (es) 2003-01-01
DE69901840T2 (de) 2003-05-22
NO20010718L (no) 2001-02-12
AU761715B2 (en) 2003-06-05
CN1146558C (zh) 2004-04-21
IL141328A0 (en) 2002-03-10
WO2000010995A1 (en) 2000-03-02
MXPA01001758A (es) 2002-04-17
DE122005000049I2 (de) 2007-03-29
PL345993A1 (en) 2002-01-14
BG65255B1 (bg) 2007-10-31
TR200100287T2 (tr) 2001-07-23
HK1037616A1 (en) 2002-02-15
BG105173A (en) 2001-11-30
CA2341031A1 (en) 2000-03-02
RS50071B (sr) 2009-01-22
EP1105386B1 (en) 2002-06-12
JP2002523411A (ja) 2002-07-30

Similar Documents

Publication Publication Date Title
PL345993A1 (en) Novel salt form of pantoprazole
MY138238A (en) Substituted benzopyran analogs for the treatment of inflamamtion
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
BG105028A (en) Bridged indenopyrrolocarbazoles
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
HK1041907A1 (zh) 製備氯化鎂溶液的方法
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
MXPA04003755A (es) Endoprotesis vasculares.
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
AP2001002274A0 (en) Rescorcinol derivatives.
MXPA03008946A (es) Metodos para sintetizar compuestos que contienen fenol.
BG103649A (en) Method for the preparation of eprosartan
BG103650A (en) Method for the preparation of eprosartan
YU29600A (sh) Korišćenje ketolida za dobijanje farmaceutskih preparata za prevenciju trombičnih arterijskih komplikacija povezanih sa arterosklerozom
GC0000101A (en) Novel composition for the prophylaxis of hepatitis.
ZA99293B (en) Production of alkyl esters.
TR199900757A3 (tr) Fenoksifenilsülfonil halidlerin hazirlanmasi için islem.
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
HUP0201573A3 (en) Method for the preparation of 2-methoxy-4-(t-butylamino-carbonyl)-benzenesulfonyl chloride
SI1202960T1 (en) Method for the preparation of 2-methoxy-4-(n-t-butylamino-carbonyl)-benzenesulfonyl chloride
FI982810A0 (fi) Menetelmä 3-asetoksi-2-metyylibentsoyylikloridin valmistamiseksi
IT1305242B1 (it) Preparatore di mazzi di pelli.